Kyowa Kirin

Kyowa Kirin is a global pharmaceutical and biotechnology firm dedicated to enhancing people's health and well-being around the world. Kyowa Kirin was formed in 1949 in Japan and has since grown to become a global corporation with operations in Europe, the Americas, and Asia. The company's primary focus is on the development and commercialization of specialty medicines and biologics in oncology, neurology, nephrology, immunology, and allergies. The objective of the organization is to develop new solutions that solve unmet medical requirements and make a significant difference in the lives of patients.

The research and development efforts of Kyowa Kirin are centered on discovering and developing innovative medicines that meet large unmet medical needs. The company is developing a robust pipeline of pharmaceuticals, including numerous potential first-in-class and best-in-class therapies. In addition to its pharmaceutical and biotechnology operations, Kyowa Kirin has a thriving chemical division that manufactures a variety of fine chemicals and intermediates for use in pharmaceutical, biotechnology, and other sectors.

Founded: 1949

Headquarters: Tokyo, Japan

Official website: https://www.kyowakirin.com/index.html